Core sedating antihistamine product information

Posted by / 01-Dec-2019 09:30

Core sedating antihistamine product information

Claritin-D 24 Hour (loratadine and pseudoephedrine sulfate) extended-release tablets prescribing information. Schering Corp, Kenilworth, NJ: Personal communication. A comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of 3- to 6-year-old children with seasonal allergic rhinitis. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Claritin-D 12 Hour (loratadine and pseudoephedrine sulfate) extended-release tablets prescribing information. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. Goodman and Gilman’s the pharmacologic basis of therapeutics. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis.

Pharmacokinetic-pharmacodynamic relationships of H- antihistamines.

Loratadine: a preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Over-the-counter drugs: establishment of a monograph for OTC cold, cough, allergy, bronchodilator and antiasthmatic products.

Focus on loratadine: a new second-generation nonsedating H1-receptor antagonist.

Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.

core sedating antihistamine product information-52core sedating antihistamine product information-17core sedating antihistamine product information-74

N-substituted 11-(4-piperidylene)-5,6-dihydro-11H-benzo-[5,6]cyclohepta[1,2b]pyrid ines.